$21.02
0.472.29%
At Close: -
$21.39
0.371.76%
After Hours: 7:45 PM EDT
15 minutes delayed
Arcturus Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Arcturus Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-05 | $-0.64 | $-1.60 | 60.0 % |
Mar 2024 | 2024-05-08 | $-1.00 | $-1.19 | 16.0 % |
Dec 2023 | 2024-03-07 | $-0.32 | $-0.99 | 67.7 % |
Sep 2023 | 2023-11-14 | $-0.61 | $-1.69 | 63.9 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-05 | $49.86M | $21.70M | 129.8 % |
Mar 2024 | 2024-05-08 | $38.01M | $17.54M | 116.7 % |
Dec 2023 | 2024-03-07 | $33.99M | $37.86M | -10.2 % |
Sep 2023 | 2023-11-14 | $45.14M | $15.86M | 184.6 % |
Arcturus Therapeutics (ARCT) is scheduled to report earnings on November 12, 2024. The last reported earnings were for reported on August 5, 2024 for Q2.
The Actual EPS was $-0.64, which beat the estimate of $-1.60.
The Actual Revenue was $49.9M, which beat the estimate of $21.7M.
Browse earnings estimates, EPS, and revenue on all stocks.